Company Filing History:

14 out of 1,451

Sanofi

Years Active: 1977-1993

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5215988 - Aminoalkoxyphenyl derivatives, process of preparation and compositions (1993-06-01),

2. 5182291 - Pyrozala-pyridyl aminoabkoxyphenol compounds (1993-01-26),

3. 5039700 - Benzofuranyl aminoalkoxyphenyl compounds (1991-08-13),

4. 5017579 - Use of aminoalkoxyphenyl derivatives for reducing and/or controlling (1991-05-21),

5. 4977274 - 4-hydroxyindole derivatives, the process for preparation thereof and (1990-12-11),

6. 4965401 - Process for the preparation of 2-propyl-2-pentenoic acid and its esters (1990-10-23),

7. 4957925 - Aminoalkoxyphenyl derivatives, process of preparation and compositions (1990-09-18),

8. 4816598 - 4-Amino-butanoic acid derivatives (1989-03-28),

9. 4814485 - 4-aminobutanoic acid derivatives, process of preparation and use thereof (1989-03-21),

10. 4791137 - Pharmaceutical and veterinary compositions for the treatment of ischemic (1988-12-13),

11. 4661514 - Pharmaceutical and veterinary compositions for the treatment of ischemic (1987-04-28),

12. 4575513 - Pharmaceutical and veterinary compositions for the treatment of ischemic (1986-03-11),

13. 4565828 - Benzofuran derivatives and their therapeutic use (1986-01-21),

14. 4374841 - Pyridoxine derivatives, and use in therapeutics (1983-02-22),

15. 4330542 - N(Sulfonyl)anilines for treating angina pectoris (1982-05-18),

Title: Marcel Descamps: A Pioneering Inventor in the Field of Aminoalkoxyphenyl Derivatives

Introduction:

Marcel Descamps, a talented inventor hailing from Wavre, Belgium, has made significant contributions to the world of pharmaceuticals and cardiovascular health. With an impressive portfolio of 19 patents and specialization in aminoalkoxyphenyl compounds, Descamps has marked his place as a notable figure in the field of medical innovations.

Latest Patents:

One of Descamps' recent patents is the development of aminoalkoxyphenyl derivatives. These compounds, characterized by the formula ##STR1## have shown promising potential for the treatment of various cardiovascular syndromes. By employing compounds containing groups such as --S--, --SO--, and --SO2--, Descamps explores new avenues for combating critical pathological conditions.

Career Highlights:

Throughout his illustrious career, Descamps has worked with renowned companies such as Sanofi and Labaz (Laboratoires d'Application Biologique). With deep expertise in the field of pharmaceuticals and extensive knowledge of aminoalkoxyphenyl derivatives, Descamps has not only made groundbreaking discoveries but has also played a vital role in implementing his research into practical applications.

Collaborations:

Descamps has collaborated with several prominent figures in the industry, including Jean Gubin and Dino Nisato. These collaborations have undoubtedly fostered an environment of innovation, allowing for the exchange of expertise and ideas that have propelled Descamps' inventions to new heights. Working alongside these esteemed colleagues has undoubtedly contributed to the success of his patents.

Conclusion:

Marcel Descamps' profound expertise in aminoalkoxyphenyl compounds and his dedication to the field of pharmaceuticals have resulted in a remarkable collection of 19 patents. His incessant drive to tackle critical cardiovascular syndromes has opened new doors in the field of medical innovation. Descamps' contributions have not only enhanced our understanding of these pathological conditions but have also provided potential solutions for better patient outcomes. As the world eagerly awaits Descamps' upcoming inventions, it is clear that his work will continue to shape the future of pharmaceutical advancements and the treatment of cardiovascular disorders.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com